Follistatin-like 1 in Cardiovascular Disease and Inflammation

(E-pub Ahead of Print)

Author(s): Marijn M.C. Peters*, Timion A. Meijs*, Wouter Gathier, Pieter A.M. Doevendans, Joost P.G. Sluijter, Steven A.J. Chamuleau, Klaus Neef.

Journal Name: Mini-Reviews in Medicinal Chemistry

Become EABM
Become Reviewer


Follistatin-like 1 (FSTL1), a secreted glycoprotein, has been shown to participate in regulating developmental processes and to be involved in states of disease and injury. Spatiotemporal regulation and posttranslational modifications contribute to its specific functions and make it an intriguing candidate to study disease mechanisms and potentially develop new therapies. With cardiovascular diseases as the primary cause of death worldwide, clarification of mechanisms underlying cardiac regeneration and revascularization remains essential. Recent findings on FSTL1 in both acute coronary syndrome and heart failure emphasize its potential as a target for cardiac regenerative therapy. With this review, we aim to shed light on the role of FSTL1 specifically in cardiovascular disease and inflammation.

Keywords: Follistatin-Like 1, FSTL1, cardiac regeneration, inflammation, cardiovascular diseases, glycoprotein, cardiomyocytes

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1389557519666190312161551
Price: $95

Article Metrics

PDF: 7